Updated: January 25, 2026
What Is Urocit-K XR? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Summarize with AI
A complete guide to Urocit-K XR (potassium citrate ER): what it treats, how to take it, available strengths, who should avoid it, and how to save money in 2026.
Urocit-K XR is the brand name for potassium citrate extended-release tablets — a prescription medication used primarily to prevent kidney stones and treat renal tubular acidosis. If you've just been prescribed this drug or are trying to understand what a family member was prescribed, this guide covers everything you need to know.
What Is Urocit-K XR?
Urocit-K XR (generic name: potassium citrate extended release) is a citrate salt of potassium manufactured by Mission Pharmacal. It was first approved by the FDA in 1985 and is classified as a urinary pH modifier. In plain terms, it makes the urine less acidic — which prevents certain types of kidney stones from forming or growing.
The "XR" in Urocit-K XR stands for extended release. Unlike immediate-release potassium supplements that deliver a large dose at once, the wax-matrix extended-release tablet delivers potassium citrate gradually over several hours, which is easier on the digestive system and maintains more consistent urinary pH throughout the day.
What Is Urocit-K XR Used For?
Urocit-K XR has three FDA-approved indications:
Hypocitraturic calcium oxalate nephrolithiasis: Kidney stones made of calcium oxalate that form because the urine doesn't contain enough citrate (a natural stone inhibitor). This is the most common use.
Uric acid lithiasis (with or without calcium stones): Kidney stones made of uric acid, which form in overly acidic urine. Raising urinary pH dissolves existing uric acid stones and prevents new ones.
Renal tubular acidosis (RTA) with calcium stones: A kidney condition in which the kidneys can't properly acidify the urine, leading to metabolic acidosis and calcium stone formation.
Available Strengths and Dosage Forms
Urocit-K XR is available in three tablet strengths:
5 mEq (540 mg potassium citrate): Tan to yellowish, modified ball shaped, "MPC 600" on one side
10 mEq (1080 mg potassium citrate): Tan to yellowish, elliptical, "610" on one side, "MISSION" on the other
15 mEq (1620 mg potassium citrate): Tan to yellowish, modified rectangle, "M15" on one side
How Much Do You Take? (Typical Dosing)
Your dose depends on how severe your hypocitraturia is, as measured by a 24-hour urine test:
Severe hypocitraturia (urinary citrate < 150 mg/day): 60 mEq/day — typically 30 mEq twice daily or 20 mEq three times daily
Mild to moderate hypocitraturia (urinary citrate > 150 mg/day): 30 mEq/day — typically 15 mEq twice daily or 10 mEq three times daily
Maximum dose: 100 mEq/day (doses above this have not been studied)
The goal of treatment is to raise urinary citrate above 320 mg/day (ideally 640 mg/day) and raise urinary pH to 6.0–7.0. Your doctor will adjust your dose based on follow-up 24-hour urine tests every four months.
How to Take Urocit-K XR Correctly
Always take with food or within 30 minutes after a meal or bedtime snack
Swallow tablets whole — do not crush, cut, or chew
Drink at least 2 liters of water per day
Follow a low-sodium diet (limit to 2,000 mg sodium per day)
Do not stop taking without talking to your doctor — missing doses allows stone-forming conditions to return
Who Should Not Take Urocit-K XR?
Urocit-K XR is contraindicated in patients with:
Hyperkalemia or conditions predisposing to high potassium (chronic kidney disease, uncontrolled diabetes, adrenal insufficiency)
Delayed gastric emptying, intestinal obstruction, or esophageal stricture
Active peptic ulcer disease
Active urinary tract infection with urea-splitting organisms
Significant kidney impairment (GFR < 0.7 mL/kg/min)
For a detailed look at side effects and warnings, see our guide: Urocit-K XR Side Effects: What to Expect and When to Call Your Doctor.
If you have a prescription and need help finding Urocit-K XR in stock near you, medfinder can check pharmacies in your area.
Frequently Asked Questions
Urocit-K XR (potassium citrate extended release) is FDA-approved to treat three conditions: hypocitraturic calcium oxalate kidney stones, uric acid kidney stones (with or without calcium), and renal tubular acidosis with calcium stone formation. It works by raising urinary pH and citrate levels, making urine less favorable for stone formation.
Urocit-K XR is available in three strengths: 5 mEq, 10 mEq, and 15 mEq extended-release tablets. All three are available in both brand-name Urocit-K and FDA-approved generic formulations. The 10 mEq strength is the most commonly prescribed and widely stocked.
Take Urocit-K XR with food or within 30 minutes after a meal or snack to reduce stomach upset. Swallow tablets whole — do not crush or chew. Drink at least 2 liters of water per day. Follow a low-sodium diet. Take the medication at evenly spaced times throughout the day (2–3 times daily as prescribed).
No. Potassium citrate extended release is not a controlled substance and is not scheduled by the DEA. It can be prescribed by any licensed prescriber, including via telehealth, and can be transferred between pharmacies without restrictions.
Urocit-K and Urocit-K XR refer to the same product — potassium citrate extended release tablets manufactured by Mission Pharmacal. All formulations are extended release via a wax-matrix tablet. The 'XR' designation is sometimes used to clarify the extended-release nature but is not a separate product from plain 'Urocit-K.'
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Urocit-K XR also looked for:
More about Urocit-K XR
30,781 have already found their meds with Medfinder.
Start your search today.





